BiosystemsCell BiologyPeer-reviewed journal article
SIMULATING TUMOR MITOCHONDRIAL ENERGETICS THROUGH ENGINEERING-STYLE ENERGY METRICS
Abstract
Cancer progression is linked to alterations in cellular energetics, where malignant cells reprogram their metabolism to sustain proliferation, resist stress and adapt to nutrient limitations. Beyond intrinsic adaptations and plastic dynamic switches between glycolysis and oxidative phosphorylation, recent work has shown that tumors actively remodel their microenvironment by acquiring functional mitochondria from surrounding stromal or immune cells. This process of mitochondrial transfer enhances tumor bioenergetics while simultaneously depleting immune cells of metabolic competence, thereby reinforcing both tumor growth and immune evasion. Despite the role of these mitochondrial exchanges, quantitative frameworks to measure their energetic consequences remain underdeveloped. Conventional assays describe oxygen consumption or glycolytic flux but lack the resolution to capture mitochondrial function in terms of throughput, efficiency and stored energy. To address this limitation, we propose a simulation-based framework that translates engineering-style energy metrics into mitochondrial biology. Specifically, we calculate three parameters that may capture distinct yet complementary aspects of mitochondrial bioenergetics: power density, defined as ATP production per unit mitochondrial volume; surface power density, reflecting ATP production per unit inner membrane area; and energy density, quantifying stored chemical free energy per unit volume. By simulating tumor and immune cell populations before and after mitochondrial transfer, we generate numerical values for each parameter that demonstrate how transfer enhances tumor energetics while diminishing immune function. This provisional quantification establishes a pathway toward standardized bioenergetic biomarkers in cancer, potentially enhancing diagnostic methods and supporting the development of strategies aimed at disrupting pathogenic mitochondrial transfer while restoring metabolic competence to immune cells.
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 6th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mitochondria redistribution organizes the immunosuppressive tumor ecosystem
Azusa Terasaki, Alexis T. Weiner, … Derick K. Okwan-Duodu·bioRxiv·Nov 11, 2025
- Mitochondrial transfer between breast cancer cells promotes ROS-dependent proliferation
Noah Michael Bressler, Taylor Zenobia Stevens, Minna Roh‐Johnson·bioRxiv·Aug 27, 2026
- Tumor-derived mitochondria enhance CD8+ T cell cytotoxicity through SPHK2-dependent S1P signaling
Chuanfang Chen, Xiunan Wang, … Shih‐Chin Cheng·bioRxiv·May 17, 2026
- HER2-driven mammary tumorigenesis enhances bioenergetics despite reductions in mitochondrial content
Sara M. Frangos, Henver S. Brunetta, … Graham P. Holloway·bioRxiv·Nov 3, 2024
- Laterally transferred macrophage mitochondria acts as a signaling source promoting cancer cell proliferation
C. U. Kidwell, J. R. Casalini, … M. Roh-Johnson·bioRxiv·Aug 10, 2021
- Tunneling nanotubes mediate mitochondrial homeostasis in cancer
Inés Sáenz‐de‐Santa‐María, Anna Pepe, … Chiara Zurzolo·bioRxiv·Jun 15, 2026